{
    "eid": "2-s2.0-84992418561",
    "title": "Estimating the impact of expanding treatment coverage and allocation strategies for chronic hepatitis c in a direct antiviral agent era",
    "cover-date": "2016-09-01",
    "subject-areas": [
        {
            "$": "Multidisciplinary",
            "@code": "1000"
        }
    ],
    "keywords": [],
    "authors": [
        "Kittiyod Poovorawan"
    ],
    "citedby-count": 13,
    "ref-count": 39,
    "ref-list": [
        "A Public Health Approach to Hepatitis C Control in Low- and Middle-Income Countries",
        "Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies",
        "Evolving epidemiology of hepatitis C virus",
        "Changing trends in hepatitis C-related mortality in the United States, 1995-2004",
        "Global epidemiology and genotype distribution of the hepatitis C virus infection",
        "Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence",
        "Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy",
        "Interferon-free, direct-acting antiviral therapy for chronic hepatitis C",
        "Treatment of hepatitis C a systematic review",
        "Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C",
        "Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy",
        "Seroepidemiology and genotypes of hepatitis C virus in Thailand",
        "Hepatitis B and hepatitis C Virus in Thai blood donors",
        "Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand",
        "A model of bi-mode transmission dynamics of hepatitis C with optimal control",
        "IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6",
        "Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels",
        "Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression",
        "Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development",
        "EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma",
        "Hepatitis C virus infection among injection drug users: Survival analysis of time to seroconversion",
        "Chronic hepatitis C infection",
        "Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience",
        "Treatment of hepatitis C as prevention: a modeling case study in Vietnam.",
        "Infection with hepatitis C virus among intravenous-drug users: Prevalence, genotypes and risk-factor-associated behaviour patterns in Thailand",
        "Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand",
        "Hepatitis C virus seroprevalence in the general female population from 8 countries",
        "Prevalence and risk factors for hepatitis C virus infection among young Thai men",
        "Decreasing hepatitis C virus infection in Thailand in the past decade: Evidence from the 2014 national survey",
        "An algorithm for the grading of activity in chronic hepatitis C",
        "Natural history of hepatitis C",
        "Thai Red Cross Organ Donation Center",
        "A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis",
        "Expanding access to treatment for hepatitis C in resource-limited settings: Lessons from HIV/AIDS",
        "Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008",
        "Evolution of the HCV viral population from a patient with S282T detected at relapse after sofosbuvir monotherapy",
        "Clinical impact of treatment timing for chronic hepatitis C infection: A decision model",
        "Genotypic distribution of hepatitis C virus in Thailand and Southeast Asia",
        "Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: A cross-sectional study"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nakhon Pathom",
            "affilname": "Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Oxford",
            "affilname": "Nuffield Department of Medicine",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": []
}